TipRanks
N4 Pharma PLC (DE:0GO)
FRANKFURT:0GO
Germany Market
0GO
N4 Pharma
RESEARCH TOOLSreports

N4 Pharma (0GO) Ratios

0 Followers

N4 Pharma Ratios

DE:0GO's free cash flow for Q4 2025 was £0.00. For the 2025 fiscal year, DE:0GO's free cash flow was decreased by £ and operating cash flow was £-177.36. See a summary of the company’s cash flow.
Ratios
TTM
Dec 25Dec 24Dec 23Dec 22
Liquidity Ratios
Current Ratio
 11.93 11.93 6.24 14.86 27.81
Quick Ratio
 11.93 11.93 6.24 14.86 27.81
Cash Ratio
 11.02 11.02 5.03 12.57 24.64
Solvency Ratio
 -12.30 -12.30 -8.52 -14.44 -10.28
Operating Cash Flow Ratio
 -11.85 -11.85 -7.81 -14.79 -10.63
Short-Term Operating Cash Flow Coverage
 0.00 0.00 0.00 0.00 0.00
Net Current Asset Value
£ 1.07M£ 1.07M£ 651.40K£ 1.13M£ 2.09M
Leverage Ratios
Debt-to-Assets Ratio
 0.00 0.00 0.00 0.00 0.00
Debt-to-Equity Ratio
 0.00 0.00 0.00 0.00 0.00
Debt-to-Capital Ratio
 0.00 0.00 0.00 0.00 0.00
Long-Term Debt-to-Capital Ratio
 0.00 0.00 0.00 0.00 0.00
Financial Leverage Ratio
 1.09 1.09 1.20 1.13 1.04
Debt Service Coverage Ratio
 0.00 0.00 0.00 0.00 0.00
Interest Coverage Ratio
 0.00 0.00 0.00 0.00 0.00
Debt to Market Cap
 0.00 0.00 0.00 0.00 0.00
Interest Debt Per Share
 0.00 0.00 0.00 0.00 0.00
Net Debt to EBITDA
 0.98 0.98 0.51 0.77 1.61
Profitability Margins
Gross Profit Margin
0.00%0.00%100.00%100.00%0.00%
EBIT Margin
-15199.56%-15199.56%-16767.37%-72964.67%0.00%
EBITDA Margin
-15199.56%-15199.56%-16767.37%-68356.37%0.00%
Operating Profit Margin
-15199.56%-15199.56%-16767.37%-72964.67%0.00%
Pretax Profit Margin
-15199.56%-15199.56%-16767.37%-72964.67%0.00%
Net Profit Margin
-16589.87%-16589.87%-14542.71%-64976.96%0.00%
Continuous Operations Profit Margin
-16632.89%-16632.90%-15380.39%-65386.58%0.00%
Net Income Per EBT
109.15%109.15%86.73%89.05%86.25%
EBT Per EBIT
100.00%100.00%100.00%100.00%100.00%
Return on Assets (ROA)
-103.13%-103.13%-136.51%-99.50%-47.51%
Return on Equity (ROE)
-84.97%-112.64%-163.52%-112.54%-49.28%
Return on Capital Employed (ROCE)
-103.14%-103.14%-187.44%-119.38%-57.13%
Return on Invested Capital (ROIC)
-103.14%-103.14%-171.94%-106.98%-49.28%
Return on Tangible Assets
-103.13%-103.13%-136.51%-104.52%-47.51%
Earnings Yield
-25.18%-31.69%-59.26%-61.47%-29.84%
Efficiency Ratios
Receivables Turnover
 0.10 0.10 0.05 0.01 0.00
Payables Turnover
 0.00 0.00 0.00 0.00 0.00
Inventory Turnover
 0.00 0.00 0.00 0.00 0.00
Fixed Asset Turnover
 0.00 0.00 0.00 0.00 0.00
Asset Turnover
 <0.01 <0.01 <0.01 <0.01 0.00
Working Capital Turnover Ratio
 <0.01 <0.01 <0.01 <0.01 0.00
Cash Conversion Cycle
 3.71K 3.71K 6.75K 32.97K 0.00
Days of Sales Outstanding
 3.71K 3.71K 6.75K 32.97K 0.00
Days of Inventory Outstanding
 0.00 0.00 0.00 0.00 0.00
Days of Payables Outstanding
 0.00 0.00 0.00 0.00 0.00
Operating Cycle
 3.71K 3.71K 6.75K 32.97K 0.00
Cash Flow Ratios
Operating Cash Flow Per Share
 >-0.01 >-0.01 >-0.01 >-0.01 >-0.01
Free Cash Flow Per Share
 >-0.01 >-0.01 >-0.01 >-0.01 >-0.01
CapEx Per Share
 <0.01 <0.01 0.00 0.00 <0.01
Free Cash Flow to Operating Cash Flow
 1.00 1.00 1.00 1.00 1.00
Dividend Paid and CapEx Coverage Ratio
 -387.06K -232.23K 0.00 0.00 -276.09K
Capital Expenditure Coverage Ratio
 -387.06K -232.23K 0.00 0.00 -276.09K
Operating Cash Flow Coverage Ratio
 0.00 0.00 0.00 0.00 0.00
Operating Cash Flow to Sales Ratio
 -159.85 -159.85 -133.41 -619.10 0.00
Free Cash Flow Yield
-24.26%-30.53%-54.36%-58.56%-24.02%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
 -3.38 -3.09 -1.69 -1.63 -3.35
Price-to-Sales (P/S) Ratio
 658.81 523.56 245.40 1.06K 0.00
Price-to-Book (P/B) Ratio
 4.47 3.55 2.76 1.83 1.65
Price-to-Free Cash Flow (P/FCF) Ratio
 -4.12 -3.28 -1.84 -1.71 -4.16
Price-to-Operating Cash Flow Ratio
 -4.12 -3.28 -1.84 -1.71 -4.16
Price-to-Earnings Growth (PEG) Ratio
 -0.05 0.07 0.04 0.30 0.09
Price-to-Fair Value
 4.47 3.55 2.76 1.83 1.65
Enterprise Value Multiple
 -3.36 -2.47 -0.95 -0.78 -1.28
Enterprise Value
 3.71M 2.72M 1.16M 1.04M 1.53M
EV to EBITDA
 -3.36 -2.47 -0.95 -0.78 -1.28
EV to Sales
 510.23 374.97 159.44 531.21 0.00
EV to Free Cash Flow
 -3.19 -2.35 -1.20 -0.86 -1.85
EV to Operating Cash Flow
 -3.19 -2.35 -1.20 -0.86 -1.85
Tangible Book Value Per Share
 <0.01 <0.01 <0.01 <0.01 0.01
Shareholders’ Equity Per Share
 <0.01 <0.01 <0.01 <0.01 0.01
Tax and Other Ratios
Effective Tax Rate
 -0.09 -0.09 0.08 0.10 0.14
Revenue Per Share
 <0.01 <0.01 <0.01 <0.01 0.00
Net Income Per Share
 >-0.01 >-0.01 >-0.01 >-0.01 >-0.01
Tax Burden
 1.09 1.09 0.87 0.89 0.86
Interest Burden
 1.00 1.00 1.00 1.00 1.00
Research & Development to Revenue
 12.65 12.65 53.61 317.15 0.00
SG&A to Revenue
 140.35 140.35 115.08 367.63 0.00
Stock-Based Compensation to Revenue
 0.00 0.00 1.01 1.76 0.00
Income Quality
 0.96 0.96 0.87 0.95 0.80
Currency in GBP